BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 3083529)

  • 1. Effects of fibrin on the enhanced activation of plasminogen by urokinase and tissue plasminogen activator: role of cross-link.
    Takada A; Watahiki Y; Takada Y
    Thromb Res; 1986 Mar; 41(5):605-13. PubMed ID: 3083529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
    Takada A; Shizume K; Cho M; Takada Y
    Thromb Res; 1987 Feb; 45(4):371-81. PubMed ID: 2437668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic and immunoblotting analyses of the activation pathways of plasminogen by urokinase and tissue plasminogen activator in the plasma or clotted plasma.
    Takada A; Yoshida M; Takada Y
    Thromb Res; 1988 Jan; 49(2):193-204. PubMed ID: 3129815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enhanced activation of Glu-plasminogen by urokinase in the presence of fibrin or des A fibrin as measured by the release of B beta peptide and FDP.
    Urano T; Takada Y; Takada A
    Thromb Res; 1984 Dec; 36(5):429-35. PubMed ID: 6084324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen.
    Takada Y; Makino Y; Takada A
    Thromb Res; 1985 Aug; 39(3):289-96. PubMed ID: 4049320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fibrinogen and fibrin on the activation of Glu- and Lys-plasminogen by urokinase.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1984 Mar; 33(6):561-9. PubMed ID: 6539003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator.
    Liu JN; Gurewich V
    Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
    Gurewich V; Pannell R
    Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tranexamic acid on fibrinolysis, fibrinogenolysis and amidolysis.
    Takada A; Makino Y; Takada Y
    Thromb Res; 1986 Apr; 42(1):39-47. PubMed ID: 3705023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.
    Pannell R; Gurewich V
    Blood; 1986 May; 67(5):1215-23. PubMed ID: 3083889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clot lysis induced by a monoclonal antibody against alpha 2-plasmin inhibitor.
    Sakata Y; Eguchi Y; Mimuro J; Matsuda M; Sumi Y
    Blood; 1989 Dec; 74(8):2692-7. PubMed ID: 2510836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
    Carr ME; Alving BM
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1988 Jan; 49(2):253-63. PubMed ID: 3129817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M; Zenker M; Gaffney PJ
    Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.